Drugmaker to sell cheaper generic rival to EpiPen injectors


Associated Press

TRENTON, N.J.

Generic drugmaker Sandoz announced plans Thursday to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.

The penlike injectors are used to halt life-threatening allergic reactions to insect bites, nuts and other foods.

Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems.

Sandoz will sell a pair of injectors, under the name Symjepi, for $250 without insurance. Two other generics on the market in the U.S. cost $300 a pair, including one from EpiPen seller Mylan. The company started selling its own generic after it was blasted for repeated hikes that pushed up its list price from $94 to $608 for a pair of brand-name EpiPens.

What people pay varies, though, depending on insurance, discounts and the pharmacy.

More like this from vindy.com

Subscribe Today

Sign up for our email newsletter to receive daily news.

Want more? Click here to subscribe to either the Print or Digital Editions.